In this review
Start with the clinical question, not the catalogue
Hone describes testing, physician consultation, a personalized plan and continuing support. Its homepage emphasizes a panel of more than fifty biomarkers. [1] I would begin with the reason for seeking that assessment: a defined symptom, a treatment question or a result that needs clinical interpretation.
More measurements do not automatically mean better decisions. Ask which findings would change care and how they will be reviewed over time. A useful clinical relationship makes the next action understandable; a broad promise to optimize longevity leaves that practical question unanswered.
For what a test result can establish, read our biological-age testing guide.
The tier determines which care is being purchased
The support overview distinguishes Basic, Plus and Premium, while the main homepage highlights Basic and Premium. Basic is $25 monthly with optional paid consultations; Premium is $155 monthly and includes consults and broader follow-up. Medication is additional. [1] [2]
The overview also separates initial testing from starting treatment and notes that testing pathways affect costs. I would obtain the selected first invoice rather than infer that a membership headline covers every test or prescription. The lower tier is not automatically the appropriate tier for every medicine.
Separate the continuing components in the cost planner.
Weight care and standalone NAD are different agreements
Hone’s liraglutide page lists a compounded product from $160 monthly plus membership and labels it Premium. Its NAD page lists $199, while the async guide describes $199 without membership or a $165 member medication rate. [5] [6] [7] These should not be merged into one treatment budget or approval pathway.
The async guide says physician approval precedes payment for that route and a declined request is not charged. [7] That is a product-pathway condition, not a universal refund promise for testing or membership. Confirm which agreement applies to the actual service being considered.
Compare another multi-product care agreement in our Wellorithm review.
A healthy-aging message is not a clinical outcome
The NAD page discusses cellular mechanisms and lifespan but acknowledges that many supporting studies are animal studies not proven in humans. [6] The liraglutide page identifies a compounded preparation that is not FDA-approved. [5] Those boundaries belong beside the commercial offer.
I would not convert testimonials, general weight-loss claims or catalogue breadth into evidence that combining products extends healthspan. Each proposed treatment needs its own clinical purpose and evidence. A testing-led service can be worth assessing without assuming every intervention in the menu improves longevity.
Keep the outcome broader than scale weight with our function-and-lean-mass review.
Ongoing access has an ongoing bill
The membership FAQ says the fee continues during months when medication is skipped and cancellation is effective at the end of the current billing period. It says medication charges require explicit approval. [3] Understand which services remain useful while a prescription is paused.
The February 24 terms describe automatic subscription renewal and nonrefundable paid fees, with a separate fifteen-day notice clause for revoking payment authorization. They also distinguish the platform from independent clinical providers and pharmacies. [9] I would clarify the actual renewal and any unfulfilled order rather than assume stopping one part ends every obligation.
For a separate care and medication model, compare our Alloy review.
My assessment stays with the defined service
The state guide gives different availability by programme, tier and men’s or women’s care. [8] It does not establish that every product is available wherever a membership is offered. Check the actual proposed service at the reader’s location.
I would shortlist Hone when the clinical question, responsible clinician, relevant tests and continuing cost are clear. Compare that arrangement with another service doing the same job. A broad catalogue should make it easier to find suitable care, not replace the explanation of why a particular treatment is appropriate.
Build a purpose-specific shortlist in our service comparisons.
Understanding the cost
Basic $25/month and Premium $155/month exclude medicines; optional consultations, onboarding and testing arrangements vary. Liraglutide from $160/month plus membership; NAD async $199 without membership/$165 member medication price plus membership. These are distinct offers, not a combined healthspan package or verified complete bill. [1] [2] [5] [7]
Build your cost estimateSources
- Hone homepage: current membership prices, medication exclusions and care model
- Hone membership overview: initial and recurring tier fees, labs and medication exclusions
- Hone membership FAQ: medication approval, ongoing billing and cancellation
- Hone current weight-care menu: named medicines and membership conditions
- Hone compounded liraglutide: from-price, Premium tier and nonapproval disclosure
- Hone NAD+ injections: current product description and evidence qualifications
- Hone current async-care guide: standalone NAD price, physician review and charging
- Hone state availability: separate programmes and location limits
- Hone terms revised February 24, 2026: clinical parties, subscriptions, payment authorization and refunds
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.